We are live on ! Find out more
CYTK icon

Cytokinetics

85 hedge funds and large institutions have $69.6M invested in Cytokinetics in 2014 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 34 increasing their positions, 17 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 17

4% less funds holding

Funds holding: 8985 (-4)

31% less capital invested

Capital invested by funds: $101M → $69.6M (-$30.9M)

31% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 13

35% less call options, than puts

Call options by funds: $561K | Put options by funds: $869K

Holders
85
Holders Change
-4
Holders Change %
-4.49%
% of All Funds
2.47%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
34
Reduced
17
Closed
13
Calls
$561K
Puts
$869K
Net Calls
-$308K
Net Calls Change
+$699K
Name Holding Trade Value Shares
Change
Change in
Stake
NI
26
Numeric Investors
Massachusetts
$556K +$664K +157,952 New
Group One Trading
27
Group One Trading
Illinois
$508K -$560K -133,321 -48%
PAI
28
Palo Alto Investors
California
$435K
HCM
29
Highbridge Capital Management
New York
$431K +$415K +98,738 +420%
California Public Employees Retirement System
30
California Public Employees Retirement System
California
$423K
BIM
31
BlackRock Investment Management
Delaware
$412K +$15.3K +3,640 +3%
Jacobs Levy Equity Management
32
Jacobs Levy Equity Management
New Jersey
$392K +$468K +111,446 New
Dimensional Fund Advisors
33
Dimensional Fund Advisors
Texas
$371K
Citadel Advisors
34
Citadel Advisors
Florida
$303K +$264K +62,843 +270%
Goldman Sachs
35
Goldman Sachs
New York
$273K +$262K +62,473 +417%
Susquehanna International Group
36
Susquehanna International Group
Pennsylvania
$267K -$528K -125,791 -62%
PAM
37
Panagora Asset Management
Massachusetts
$266K +$314K +74,806 +9,702%
KeyBank National Association
38
KeyBank National Association
Ohio
$251K +$130K +30,846 +76%
Allianz Asset Management
39
Allianz Asset Management
Germany
$244K -$832K -198,151 -74%
CS
40
Credit Suisse
Switzerland
$233K -$136K -32,379 -33%
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$224K +$1.52K +363 +0.6%
NCCM
42
Nine Chapters Capital Management
New Jersey
$182K +$217K +51,600 New
TC
43
TFS Capital
Pennsylvania
$172K +$131K +31,277 +178%
SIP
44
Stoneridge Investment Partners
Pennsylvania
$169K
Charles Schwab
45
Charles Schwab
California
$162K
American Century Companies
46
American Century Companies
Missouri
$148K +$177K +42,052 New
CCMH
47
Cornerstone Capital Management Holdings
New York
$146K +$122K +29,000 +231%
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$145K
QI
49
Quotient Investors
New York
$132K
Alyeska Investment Group
50
Alyeska Investment Group
Illinois
$109K -$14.8K -3,532 -10%

CYTK Hedge Fund Activity: Q3 2014 in Review

85 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q3 2014, worth a combined $69.6M — down 31% from $101M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of CYTK and 9 opened new positions — a net loss of 4 holders — while 17 trimmed existing stakes and 34 added.

The largest buyer was Wasatch Advisors, adding an estimated $2.02M. The largest seller was Alpha Wave Global, exiting entirely with an estimated $8.53M sold.

  • 85 institutional investors held Cytokinetics (CYTK) as of Q3 2014, down from 89 in Q2 2014.
  • Funds reported $69.6M of Cytokinetics stock for Q3 2014, down 31% quarter-over-quarter.
  • 9 funds opened new Cytokinetics positions in Q3 2014 and 13 closed out, a net change of -4 holders.
  • The largest Cytokinetics buyer in Q3 2014 was Wasatch Advisors, an estimated $2.02M added.
  • The largest Cytokinetics seller in Q3 2014 was Alpha Wave Global, an estimated $8.53M sold.

Based on aggregated 13F filings for Q3 2014.